BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 17927463)

  • 1. Increasing pneumococcal vaccination in managed care through telephone outreach.
    Winston CA; Mims AD; Leatherwood KA
    Am J Manag Care; 2007 Oct; 13(10):581-8. PubMed ID: 17927463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A health plan intervention to improve pneumococcal vaccination in the elderly.
    Yanagihara DM; Taira DA; Davis J; Gronley KA; Marciel C; Lee E; Tice A
    Manag Care Interface; 2005 Sep; 18(9):25-30. PubMed ID: 16209136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of community dwelling elderly not vaccinated for pneumococcus in 1998 and 2001.
    Hoover DR; Sambamoorthi U; Crystal S
    Prev Med; 2004 Sep; 39(3):517-27. PubMed ID: 15313091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates.
    Szilagyi PG; Humiston SG; Gallivan S; Albertin C; Sandler M; Blumkin A
    Arch Pediatr Adolesc Med; 2011 Jun; 165(6):547-53. PubMed ID: 21646588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving rates of pneumococcal vaccination on discharge from a tertiary center medical teaching unit: a prospective intervention.
    Thomas CM; Loewen A; Coffin C; Campbell NR
    BMC Public Health; 2005 Oct; 5():110. PubMed ID: 16225683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of appointment reminders on vaccination coverage at an urban clinic.
    Irigoyen MM; Findley S; Earle B; Stambaugh K; Vaughan R
    Pediatrics; 2000 Oct; 106(4 Suppl):919-23. PubMed ID: 11044144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
    Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
    Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain.
    Jiménez-García R; Ariñez-Fernandez MC; Hernández-Barrera V; Garcia-Carballo MM; de Miguel AG; Carrasco-Garrido P
    J Infect; 2007 Jan; 54(1):65-74. PubMed ID: 17049991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation and evaluation of a nursing assessment/standing orders-based inpatient pneumococcal vaccination program.
    Eckrode C; Church N; English WJ
    Am J Infect Control; 2007 Oct; 35(8):508-15. PubMed ID: 17936141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and impact of an automated telephone outreach system for asthma in a managed care setting.
    Vollmer WM; Kirshner M; Peters D; Drane A; Stibolt T; Hickey T; Tom GI; Buist AS; O'Connor EA; Frazier EA; Mosen D
    Am J Manag Care; 2006 Dec; 12(12):725-33. PubMed ID: 17149995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
    Ridda I; Lindley IR; Gao Z; McIntyre P; Macintyre CR
    Vaccine; 2008 Oct; 26(44):5633-40. PubMed ID: 18706955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing medical service utilization by encouraging vaccines: randomized controlled trial.
    Berg GD; Thomas E; Silverstein S; Neel CL; Mireles M
    Am J Prev Med; 2004 Nov; 27(4):284-8. PubMed ID: 15488357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of reminder-recall interventions on low vaccination coverage in an inner-city population.
    LeBaron CW; Starnes DM; Rask KJ
    Arch Pediatr Adolesc Med; 2004 Mar; 158(3):255-61. PubMed ID: 14993085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three methods of recalling patients for influenza vaccination.
    McDowell I; Newell C; Rosser W
    CMAJ; 1986 Nov; 135(9):991-7. PubMed ID: 3093045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of three methods for improving mammography rates in a managed care plan.
    Davis NA; Nash E; Bailey C; Lewis MJ; Rimer BK; Koplan JP
    Am J Prev Med; 1997; 13(4):298-302. PubMed ID: 9236968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study.
    Vila-Corcoles A; Salsench E; Rodriguez-Blanco T; Ochoa-Gondar O; de Diego C; Valdivieso A; Hospital I; Gomez-Bertomeu F; Raga X
    Vaccine; 2009 Mar; 27(10):1504-10. PubMed ID: 19171174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up.
    Vila-Córcoles A; Ochoa-Gondar O; Ester F; Sarrá N; Ansa X; Saún N;
    BMC Public Health; 2006 Sep; 6():231. PubMed ID: 16981982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects.
    Claes C; Reinert RR; von der Schulenburg JM
    Eur J Health Econ; 2009 Feb; 10(1):25-38. PubMed ID: 18379830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adults with invasive pneumococcal disease: missed opportunities for vaccination.
    Kyaw MH; Greene CM; Schaffner W; Ray SM; Shapiro M; Barrett NL; Gershman K; Craig AS; Roberson A; Zell ER; Schuchat A; Bennett NM; Whitney CG;
    Am J Prev Med; 2006 Oct; 31(4):286-92. PubMed ID: 16979452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
    Vila-Córcoles A; Ochoa-Gondar O; Hospital I; Ansa X; Vilanova A; Rodríguez T; Llor C;
    Clin Infect Dis; 2006 Oct; 43(7):860-8. PubMed ID: 16941367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.